REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > (o=)n(=o)-o-c Containing (e.g., Nitrate Ester, Etc.) > Cyano Or Isocyano Bonded Directly To Carbon > Z-c(=o)-o-y, Wherein Z Contains A Benzene Ring > Compound Contains Two Or More C(=o)o Groups Compound Contains Two Or More C(=o)o GroupsCompound Contains Two Or More C(=o)o Groups patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/25/07 - 20070021503 - Ophthalmic fluid An ophthalmic fluid containing at least one triglyceride, diglyceride, or monoglyceride which is chemically similar or compatible with compounds found naturally in the lipid layer of the tear film of an ocular substrate. Preferably the glycerides are derived from a fatty acid containing at least one unsaturated bond in a ... 01/11/07 - 20070010580 - Formulation for chemical peeling The present invention refers to a new formulation able to increase the efficacy and the tolerability of preparations based on the use of compounds used to carry out chemical peeling. More particularly, the present invention refers to a composition for chemical peeling, comprising at least one keratolytic agent and dimethyl ... 11/23/06 - 20060264505 - Dermatological compositions Topical dermatological compositions comprising urea as an active ingredient, a vegetable oil or a derivative thereof, water, and conventional excipients. These compositions are used for topical medical applications, particularly to treat various skin disorders. ... 11/02/06 - 20060247310 - Body temperature elevating agents The present invention provides body temperature elevating agents and foods and drinks for body temperature elevation. The invention relates to the body temperature elevating agent and food and drink for the body temperature elevation, which is comprised of medium chain fatty acid and/or glycerin fatty acid ester including the medium ... 10/26/06 - 20060241182 - Antibiotic, functional cosmetic and functional food containing levulinic acid and their derivatives The present invention relates to antibiotics, functional cosmetics and functional foods comprising levulinic acid or its derivatives as effective ingredients. More particularly, the present invention relates to antibiotics comprising levulinic acid or its derivatives having antibiotic activities against various microorganisms including Gram positive bacteria, Gram negative bacteria, yeast and drug-resistant ... 10/19/06 - 20060235077 - Diverticular remodling technique A diverticular remodeling technique comprises the introduction of a remodeling agent into the diverticulum to promote permanent closure of the diverticular sac. In disclosed exemplary embodiments, the diverticulum is accessed non-invasively and optionally cleaned to remove unwanted matter therefrom. The remodeling agent is introduced into the diverticular interior and the ... 10/12/06 - 20060229364 - Antiviral compositions and methods of use Antiviral compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including, in particular, an antiviral lipid component, such as a fatty acid ester, fatty ether, or alkoxide derivative thereof. Such compositions provide effective topical antimicrobial activity and are accordingly useful in the treatment and/or prevention ... 09/28/06 - 20060217442 - Preventive or ameliorating agent for liver disease involving hepatopathy To provide a preventive or ameliorating agent for liver diseases associated with hepatopathy comprising an omega-9 unsaturated fatty acid as an active ingredient. ... 09/28/06 - 20060217441 - Lipid-improving agent and composition containing lipid-improving agent A lipid-improving agent containing a triglyceride(s) where a poly-unsaturated fatty acid is bonded to 2-position of a triglyceride(s). ... 08/17/06 - 20060183799 - Biologically active oils A process for the production of fats or oils and their extracts containing biologically-active chemical compounds from a lipid substrate, the process comprising: a) inoculation of a lipid substrate with fungally derived lipolytic enzymes b) incubating the inoculated substrate for a period of between about 7-120 days at a temperature ... 07/13/06 - 20060154986 - A triacylglyceride to deliver health promoting fatty acids to the upper gastrointestinal tract and skin wherein, each R, independently, is a fatty acid residue, either saturated or unsaturated, having between 2 and 40 carbons; each R′, independently, is a long chain omega-3-unsaturated fatty acid residue having between 16 and 40 carbons, preferably 18 to 22 carbons; and each R″, independently, is a short chain acid ... 07/06/06 - 20060148897 - Method for sterilization using in situ gelling materials A method for sterilizing a female or male patient is provided. The method comprises introducing into a reproductive duct of the patient a composition comprising a nucleophilic component, such as a thiol, and a component containing a conjugated unsaturated bond, such as an acrylate. The composition crosslinks within the reproductive ... 06/22/06 - 20060135609 - Ophthamological drugs The present invention relates generally to ophthamological drugs. More specifically, the inventon relates to a method of modifying (derivatizing) ophthamological drugs so as to increase their penetration through the cornea. The invention also relates to drugs modified (derivatized) in accordance with the instant method and to the use of same ... 06/22/06 - 20060135608 - Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia Eicosapentaenoic acid (EPA) is used in the treatment of anorexia nervosa, bulimia and related clinical syndromes. ... 04/06/06 - 20060074129 - Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes This invention is linked to the chemical, pharmaceutical and cosmetic industries, where the bactericidal, virucidal, parasiticidal and fungicidal properties of the ozonized vegetable oils and fats are considered. The emulsified vegetable oil or fat is driven to react with ozone in a bubbling reactor, covered by a jacket that makes ... 03/30/06 - 20060069156 - Acylated aminopropanediols and analogues and therapeutic uses thereof The invention relates to novel acylated aminopropanediols and the nitrogen and sulfur analogues thereof, pharmaceutical compositions comprising same, therapeutic uses thereof, in particular for the treatment of cerebral ischemia. The invention also provides a method of preparing said derivatives. ... 03/23/06 - 20060063835 - Composition based on triethyl citrate for the treatment of bacterial infections of the skin This invention concerns a composition for topical use containing as an active ingredient triethyl citrate either pure or in combination with synergists, and the pharmaceutical or cosmetic use of the composition, on its own or in association with an antibiotic, at least in the treatment of cutaneous pathologies directly or ... 02/23/06 - 20060041019 - Inhibitor of anticancer drug side effect An object of the present invention is to provide a novel agent for suppressing side effects of an antitumor agent, which can suppress side effects caused by the use of an antitumor agent, such as hair loss. The present invention provides an agent for suppressing side effects of an antitumor ... 12/08/05 - 20050272813 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis Novel synthetic forms of etherified oxidized phospholipids and methods of utilizing same for preventing and treating atherosclerosis and other related disorders, as well as inflammatory disorders, immune mediated diseases, autoimmune diseases and proliferative disorders, are provided. In addition, methods of synthesizing etherified and esterified oxidized phospholipids and of using same ... 11/17/05 - 20050256190 - Method for activating the lipid catabolic metabolism in enteric epithelium and improving the lipid metabolism in enteric epithelium Disclosed are a method for activating lipid metabolism in the small intestine epithelium and also a method for promoting accumulation of fatty acids into the small intestine epithelium, each of which features administering an effective amount of a diacylglycerol. Also disclosed are methods for improving various symptoms in diabetes, which ... 11/10/05 - 20050250848 - Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers The present invention provides compositions comprising at least one GHB moiety bonded to at least one physiologically compatible carrier molecule. The compositions can enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, or can target specific organs. ... 10/20/05 - 20050234127 - Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field Long-chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field. Use of compounds of formula R—X wherein X is a primary alcoholic functional group —CH20H, a carboxylic functional group —COON or a C1-C4 alkyl ester group, and of mono-, di- and tri-glycerides of acid compounds R—COON ... 09/15/05 - 20050203182 - Emulsification of lanolin A process for emulsifying lanolin comprising blending a mixture of lanolin, a diamine emulsifier and water wherein the mixture has pH in the range of from 2 to 7 and wherein the mixture is at a temperature of at least 40° C. wherein the diamine emulsifier is present in the ... 09/15/05 - 20050203181 - Double esters The invention provides acyloxymethyl esters of C6-14 alkane-dicarboxylic acids, or physiologically tolerable salts or esters thereof, for use in medicine as therapeutic or prophylactic agents. ... 09/08/05 - 20050197395 - Compositions and methods for body weight management The present invention is for compositions and methods for managing the body weight of a subject using said compositions. Weight management, particularly weight gain and loss, is effectuated by producing a sensation of satiety in said subjects. The method of managing body weight includes administering the composition prior to food ... 09/08/05 - 20050197394 - Endurance improver There are provided an endurance improver and an anti-fatigue agent for broadly-defined exercises including sports requiring endurance and labors requiring repeated muscle exertions. The present endurance improver and anti-fatigue agent contain diacylglycerol as an active ingredient. ... 09/01/05 - 20050192349 - Isolation of the peroxisome proliferation-activated receptor-gamma (ppargamma) ligand and methods of use thereof The present invention is drawn toward novel endogenous PPARγ ligand, the isolation of the ligand and the use of the isolated ligand to stimulate PPARγ activity in cells of interest. The invention is also drawn to diagnostic methods to detect the level of the ligand in a sample of interest. ... 09/01/05 - 20050192348 - Methods and products which utilize n-acyl-l-aspartic acid The invention provides therapeutic methods and products for the treatment of inflammation, inflammatory diseases and conditions, and proliferative diseases and conditions. The invention also provides methods and products for inhibiting inflammation in excised cells, tissues and organs. The invention further provides oral care methods and products for the treatment of ... 07/28/05 - 20050165100 - Conjugated fatty acid esters Use of conjugated fatty acid glycerides, which are formed by converting conjugated fatty acids having conjugated double bond(s) in the molecule into glycerol esters, to more effectively exert the inherent physiological effects of the conjugated fatty acids and control the bitterness or astringency of the conjugated fatty acids, thereby making ... 07/07/05 - 20050148666 - Method for activating the lipid catabolic metabolism in enteric epithelium and improving the lipid metabolism in enteric epithelium Disclosed are a method for activating lipid metabolism in the small intestine epithelium and also a method for promoting accumulation of fatty acids into the small intestine epithelium, each of which features administering an effective amount of a diacylglycerol. Also disclosed are methods for improving various symptoms in diabetes, which ... 06/30/05 - 20050143459 - Use of medium-chain triglycerides for the prevention and therapy of adiposity The use of medium-chain triglycerides or of a composition containing said medium-chain triglycerides for the prevention or therapy of overweight or adiposity is described. Said composition preferably also contains long-chain essential triglycerides, preferably α-linoleic acid and/or linolenic acid as well as, optionally, further components and/or additives. ... ### FreshPatents.com Support |